Blyuss et al. recently demonstrated in a longitudinal study that a panel of the biomarkers CA125, HE4, and glycodelin was able to detect ovarian cancer in prospectively collected samples up to one year before diagnosis34. Here, PAEP is linked to ovarian carcinoma.